Diabetes

Continuous Glucose Monitoring (CGM) & Biosensors

Continuous Glucose Monitoring (CGM) & Biosensors will delve into one of the most transformative areas in diabetes management—real-time glucose tracking technologies that are reshaping the way diabetes is monitored, controlled, and understood. Continuous Glucose Monitoring (CGM) systems, alongside advanced biosensor platforms, have revolutionized traditional blood glucose testing by offering dynamic, minute-to-minute glucose data. CGM devices measure glucose levels continuously via a small sensor inserted under the skin, typically in the abdomen or upper arm. Unlike traditional finger-stick testing, CGMs provide round-the-clock monitoring, trend data, and alerts for hypo- or hyperglycemic episodes, enabling patients and healthcare providers to make more informed, timely decisions. This real-time insight into glucose fluctuations improves glycemic control, reduces the risk of complications, and enhances quality of life, particularly for those with Type 1 diabetes or insulin-dependent Type 2 diabetes.  Non-invasive biosensors—such as those utilizing interstitial fluid, sweat, tears, or saliva—are also being researched and developed, with the goal of eliminating the need for skin punctures entirely. Smartwatches and adhesive skin patches equipped with optical sensors and microfluidic systems are paving the way for discreet, continuous health tracking.